Skip to main content
. 2014 Oct 20;33(1):42–50. doi: 10.1200/JCO.2014.56.8253

Fig 1.

Fig 1.

Kaplan-Meier survival curves of effect of BRAF V600E mutation status on disease recurrence–free probability in patients with various types of papillary thyroid cancer (PTC). Comparison of recurrence-free survival of patients, represented by indicated log-rank and P values in each panel, was performed between BRAF V600E–negative and –positive groups for (A) all patients, (B) those with conventional PTC, and (C) those with follicular-variant PTC. Follow-up time truncated at 15 years.